|
|
|
|
|
Detail |
hsa-miR-139 |
|
Unspecified |
MicroRNAs play an essential role in the development of cardiac hypertrophy. |
2008 |
|
|
|
|
|
|
hsa-miR-139 |
|
Unspecified |
Expression profiling identifies microRNA signature in pancreatic cancer. |
2006 |
|
|
|
|
|
|
hsa-miR-139 |
|
Unspecified |
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. |
2008 |
|
|
|
|
|
|
hsa-miR-139 |
|
Unspecified |
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. |
2008 |
|
|
|
|
|
|
hsa-miR-139 |
|
Unspecified |
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. |
2009 |
|
|
|
|
|
|
hsa-miR-139 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
hsa-miR-139 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
hsa-miR-139 |
|
Unspecified |
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. |
2008 |
|
|
|
|
|
|
hsa-miR-139 |
|
Unspecified |
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. |
2008 |
|
|
|
|
|
|
hsa-miR-139 |
|
Unspecified |
Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. |
2008 |
|
|
|
|
|
|